Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The VP8* domain is a proteolytically cleaved fragment of the rotavirus outer capsid spike protein, VP4. It forms the globular head of each spike on the virion surface and is essential for viral attachment to host cells. VP8* adopts a galectin-like fold and mediates initial attachment to host cell surface glycans, including histo-blood group antigens (HBGAs) and sialic acids, determining host range and tissue tropism. Interaction between rotavirus's VP8* domain and specific cell-surface glycans is critical for infection initiation, informing vaccine design strategies aimed at blocking viral entry.
Blocking viral entry through glycan/sialic acid binding inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP4-derived VP8* Domain (VP8*).